Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b

L. Riboni, R. Ghidoni, G. Tettamanti

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The presence of ganglioside GD1b, in lactone form GD1b-L, was ascertained in rat brain. The possible formation of GD1B-L from GD1b in brain was explored by the intracisternal injection of GD1b, 3H-labelled at the level of the terminal galactose. This was followed by recognition of the radioactive ganglioside formed at different times (1, 3 and 7 days) after injection. Whereas at 0 times after injection the only radioactive ganglioside was GD1b, after 1, 3, and 7 days other radioactive gangliosides were also found, thus indicating GD1b penetration into the brain tissue, followed by metabolic processing. Besides GD1b, the following radioactive gangliosides were recognized: GM1 and GM2, derived from GD1b degradation; GT1b, formed by the direct sialylation of GD1b; and GD1b-L, produced by metabolic lactonization. The radioactivity carried by GD1b-L was maximal 3 days after injection; its time course was different from that of the other gangliosides, suggesting that the process of lactonization is separate from that of both degradation and glycosylation. Under the same experimental conditions, some radioactive gangliosides also appeared in liver, although in much smaller amounts than in brain. Radioactive GD1b-L could not be detected in liver, thus indicating that metabolic lactonization is a tissue- or organ-specific process.

Original languageEnglish
Pages (from-to)1401-1406
Number of pages6
JournalJournal of Neurochemistry
Volume52
Issue number5
Publication statusPublished - 1989

Fingerprint

Gangliosides
Rats
Brain
Injections
Liver
L Forms
Tissue
Glycosylation
Degradation
Galactose
Radioactivity
Lactones
GD1b-lactone ganglioside
Processing

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b. / Riboni, L.; Ghidoni, R.; Tettamanti, G.

In: Journal of Neurochemistry, Vol. 52, No. 5, 1989, p. 1401-1406.

Research output: Contribution to journalArticle

Riboni, L, Ghidoni, R & Tettamanti, G 1989, 'Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b', Journal of Neurochemistry, vol. 52, no. 5, pp. 1401-1406.
Riboni, L. ; Ghidoni, R. ; Tettamanti, G. / Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b. In: Journal of Neurochemistry. 1989 ; Vol. 52, No. 5. pp. 1401-1406.
@article{cdff1f791f7d48fc879d0bf1ed15a331,
title = "Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b",
abstract = "The presence of ganglioside GD1b, in lactone form GD1b-L, was ascertained in rat brain. The possible formation of GD1B-L from GD1b in brain was explored by the intracisternal injection of GD1b, 3H-labelled at the level of the terminal galactose. This was followed by recognition of the radioactive ganglioside formed at different times (1, 3 and 7 days) after injection. Whereas at 0 times after injection the only radioactive ganglioside was GD1b, after 1, 3, and 7 days other radioactive gangliosides were also found, thus indicating GD1b penetration into the brain tissue, followed by metabolic processing. Besides GD1b, the following radioactive gangliosides were recognized: GM1 and GM2, derived from GD1b degradation; GT1b, formed by the direct sialylation of GD1b; and GD1b-L, produced by metabolic lactonization. The radioactivity carried by GD1b-L was maximal 3 days after injection; its time course was different from that of the other gangliosides, suggesting that the process of lactonization is separate from that of both degradation and glycosylation. Under the same experimental conditions, some radioactive gangliosides also appeared in liver, although in much smaller amounts than in brain. Radioactive GD1b-L could not be detected in liver, thus indicating that metabolic lactonization is a tissue- or organ-specific process.",
author = "L. Riboni and R. Ghidoni and G. Tettamanti",
year = "1989",
language = "English",
volume = "52",
pages = "1401--1406",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b

AU - Riboni, L.

AU - Ghidoni, R.

AU - Tettamanti, G.

PY - 1989

Y1 - 1989

N2 - The presence of ganglioside GD1b, in lactone form GD1b-L, was ascertained in rat brain. The possible formation of GD1B-L from GD1b in brain was explored by the intracisternal injection of GD1b, 3H-labelled at the level of the terminal galactose. This was followed by recognition of the radioactive ganglioside formed at different times (1, 3 and 7 days) after injection. Whereas at 0 times after injection the only radioactive ganglioside was GD1b, after 1, 3, and 7 days other radioactive gangliosides were also found, thus indicating GD1b penetration into the brain tissue, followed by metabolic processing. Besides GD1b, the following radioactive gangliosides were recognized: GM1 and GM2, derived from GD1b degradation; GT1b, formed by the direct sialylation of GD1b; and GD1b-L, produced by metabolic lactonization. The radioactivity carried by GD1b-L was maximal 3 days after injection; its time course was different from that of the other gangliosides, suggesting that the process of lactonization is separate from that of both degradation and glycosylation. Under the same experimental conditions, some radioactive gangliosides also appeared in liver, although in much smaller amounts than in brain. Radioactive GD1b-L could not be detected in liver, thus indicating that metabolic lactonization is a tissue- or organ-specific process.

AB - The presence of ganglioside GD1b, in lactone form GD1b-L, was ascertained in rat brain. The possible formation of GD1B-L from GD1b in brain was explored by the intracisternal injection of GD1b, 3H-labelled at the level of the terminal galactose. This was followed by recognition of the radioactive ganglioside formed at different times (1, 3 and 7 days) after injection. Whereas at 0 times after injection the only radioactive ganglioside was GD1b, after 1, 3, and 7 days other radioactive gangliosides were also found, thus indicating GD1b penetration into the brain tissue, followed by metabolic processing. Besides GD1b, the following radioactive gangliosides were recognized: GM1 and GM2, derived from GD1b degradation; GT1b, formed by the direct sialylation of GD1b; and GD1b-L, produced by metabolic lactonization. The radioactivity carried by GD1b-L was maximal 3 days after injection; its time course was different from that of the other gangliosides, suggesting that the process of lactonization is separate from that of both degradation and glycosylation. Under the same experimental conditions, some radioactive gangliosides also appeared in liver, although in much smaller amounts than in brain. Radioactive GD1b-L could not be detected in liver, thus indicating that metabolic lactonization is a tissue- or organ-specific process.

UR - http://www.scopus.com/inward/record.url?scp=0024583092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024583092&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 1401

EP - 1406

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -